Groundbreaking HIV cure study in South Africa shows the safety and potential efficacy of a novel therapeutic regimen in women ...

Each day more than 500 children younger than 15 years die from tuberculosis. Considerable progress has been made to control tuberculosis, but the impact on reducing the burden of childhood ...

Emory University's pioneering work with a class of small molecules known as JAK (janus kinase) inhibitors continues to show how HIV might be cured ...

System and community-level actions that firmly place the needs of people with tuberculosis in the front and centre are vital ...

Discover why private ingrown hairs pose more than cosmetic concerns, including infection risks, and learn 6 effective ...

Tuberculosis continues to cause a substantial amount of morbidity globally, with nearly 11 million people having active tuberculosis in 2023.1 Success rates for tuberculosis treatment have improved ...

Regulatory and reimbursement pathways should consider indirect benefits in addition to direct health benefits when evaluating ...

Discover how smoking attacks virtually every organ, from lung destruction and heart damage to fertility problems, weakened ...

NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-stage biotechnology company dedicated to developing novel treatments for cancer and viral infections ...

About PD-1 Inhibitors PD-1 inhibitors work by blocking the PD-1 (programmed death-1) receptor on T cells, preventing cancer cells from evading the immune system and restoring the body’s ability to ...

Federal Circuit Ruling Potentially Upends Orange Book Patent Listing Requirements, Expert Analysis Reveals This ruling marks a pivotal moment in Hatch-Waxman practice, potentially altering how ...

Here are the 156 nonprofit grantees that received grants for the 2024-2025 program cycle from The Republic's Season for ...